Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster randomized trial

被引:7
|
作者
Lee, Theresa M. [1 ,2 ]
Ivers, Noah M. [1 ,2 ,3 ,4 ,5 ]
Bhatia, Sacha [1 ,2 ,5 ,7 ]
Butt, Debra A. [4 ,6 ]
Dorian, Paul [7 ,8 ]
Jaakkimainen, Liisa [1 ,2 ,4 ,9 ]
Leblanc, Kori [10 ,11 ]
Legge, Dan [1 ]
Morra, Dante [7 ,10 ,12 ]
Valentinis, Alissia [4 ,13 ]
Wing, Laura [1 ]
Young, Jacqueline [1 ]
Tu, Karen [1 ,2 ,4 ,14 ]
机构
[1] Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, 155 Coll St,Suite 425, Toronto, ON M5T 3M6, Canada
[3] Womens Coll Hosp, Dept Family & Community Med, 77 Grenville St, Toronto, ON M5S IB3, Canada
[4] Univ Toronto, Dept Family & Community Med, 500 Univ Ave,5th Floor, Toronto, ON M5G IV7, Canada
[5] Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, 76 Grenville St, Toronto, ON M5S IB2, Canada
[6] Scarborough Gen Hosp, Dept Family & Community Med, 3030 Lawrence Ave East,Suite 414, Scarborough, ON M1P 2V5, Canada
[7] Univ Toronto, Dept Med, Suite RFE 3-805,200 Elizabeth St, Toronto, ON M5G 2C4, Canada
[8] St Michaels Hosp, Div Cardiol, 30 Bond St, Toronto, ON M5B IW8, Canada
[9] Sunnybrook Acad Family Hlth Team, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[10] Univ Hlth Network, Ctr Innovat Complex Care, 200 Elizabeth St Rm 13 N 1382, Toronto, ON M5G 2C4, Canada
[11] Univ Toronto, Leslie Dan Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada
[12] Inst Better Hlth, Trillium Hlth Partners, 2200 Eglinton Ave West, Mississauga, ON L5M 2N1, Canada
[13] Taddle Creek Family Hlth Team, 790 Bay St 522, Toronto, ON M5G IN8, Canada
[14] Univ Hlth Network, Toronto Western Hosp, Family Hlth Team, 399 Bathurst St, Toronto, ON M5T 2S8, Canada
来源
IMPLEMENTATION SCIENCE | 2016年 / 11卷
基金
加拿大健康研究院;
关键词
Atrial fibrillation; Stroke prevention; Multifaceted intervention; Cluster-randomized trial; ANTITHROMBOTIC THERAPY; DECISION AID; ANTICOAGULATION MANAGEMENT; ORAL ANTICOAGULATION; COST-EFFECTIVENESS; ELDERLY-PATIENTS; WARFARIN; PHYSICIANS; QUALITY; RISK;
D O I
10.1186/s13012-016-0523-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The prevalence of atrial fibrillation (AF) is growing as the population ages, and at least 15% of ischemic strokes are attributed to AF. However, many high-risk AF patients are not offered guideline-recommended stroke prevention therapy due to a variety of system, provider, and patient-level barriers. Methods: We will conduct a pragmatic, cluster-randomized controlled trial randomizing primary care clinics to test a " toolkit" of quality improvement interventions in primary care. In keeping with the recommendations of the chronic care model to simultaneously activate patients and facilitate proactive care by providers, the toolkit includes provider-focused strategies (education, audit and feedback, electronic decision support, and reminders) plus patient-directed strategies (educational letters and reminders). The trial will include two feedback cycles at baseline and approximately 6 months and a final data collection at approximately 12 months. The study will be powered to show a difference of 10% in the primary outcome of proportion of patients receiving guideline-recommended stroke prevention therapy. Analysis will follow the intention-to-treat principle and will be blind to treatment allocation. Unit of analysis will be the patient; models will use generalized estimating equations to account for clustering at the clinical level. Discussion: Stroke prevention therapy using anticoagulation in patients with AF is known to reduce strokes by two thirds or more in clinical trials, but most studies indicate under-use of this treatment in real-world practice. If the toolkit successfully improves care for patients with AF, stakeholders will be engaged to facilitate broader application to maximize the potential to improve patient outcomes. The intervention toolkit tested in this project could also provide a model to improve quality of care for other chronic cardiovascular conditions managed in primary care.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] The effectiveness of problem solving therapy for stroke patients: study protocol for a pragmatic randomized controlled trial
    Visser, Marieke M.
    Heijenbrok-Kal, Majanka H.
    van 't Spijker, Adriaan
    Ribbers, Gerard M.
    Busschbach, Jan J. V.
    [J]. BMC NEUROLOGY, 2013, 13
  • [32] The effectiveness of problem solving therapy for stroke patients: study protocol for a pragmatic randomized controlled trial
    Marieke M Visser
    Majanka H Heijenbrok-Kal
    Adriaan van ’t Spijker
    Gerard M Ribbers
    Jan JV Busschbach
    [J]. BMC Neurology, 13
  • [33] Primary and secondary stroke prevention for patients with atrial fibrillation in Latvia
    Jurjans, K.
    Miglane, E.
    Millers, A.
    Priede, Z.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E396 - E397
  • [34] Transient ischemic attacks in patients with atrial fibrillation - Implications for secondary prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
    Hart, RG
    Pearce, LA
    Koudstaal, PJ
    [J]. STROKE, 2004, 35 (04) : 948 - 951
  • [35] Antithrombotic therapy in atrial fibrillation: A review of randomized trials with special reference to the stroke prevention in atrial fibrillation II (SPAF II) trial
    Shivkumar, K
    Jafri, SM
    Gheorghiade, M
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1996, 38 (04) : 337 - 342
  • [36] A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation A randomized clinical trial in primary care
    Dalmau Llorca, Maria Rosa
    Queiroga Goncalves, Alessandra
    Forcadell Drago, Emma
    Fernandez-Saez, Jose
    Hernandez Rojas, Zojaina
    Pepio Vilaubi, Josep Maria
    Rodriguez Cumplido, Dolores
    Morral Parente, Rosa Maria
    Aguilar Martin, Carina
    [J]. MEDICINE, 2018, 97 (03)
  • [37] Are Primary Care Providers Meeting Guidelines for Stroke Prevention in Atrial Fibrillation?
    Cox, Jafna L.
    Parkash, Ratika
    Hamilton, Laura
    Thabane, Lehana
    Foster, Gary
    MacKillop, James
    Xie, Feng
    Ciaccia, Antonio
    Choudhri, Shurjeel
    Nemis-White, Joanna
    [J]. CIRCULATION, 2019, 140
  • [38] Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation
    Alli, Oluseun
    Doshi, Shepal
    Kar, Saibal
    Reddy, Vivek
    Sievert, Horst
    Mullin, Chris
    Swarup, Vijay
    Whisenant, Brian
    Holmes, David, Jr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (17) : 1790 - 1798
  • [39] A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation - A randomized controlled trial
    Man-Son-Hing, M
    Laupacis, A
    O'Connor, AM
    Biggs, J
    Drake, E
    Yetisir, E
    Hart, RG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08): : 737 - 743
  • [40] Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation
    Huang, Sophia
    Safavi-Naeini, Payam
    Rasekh, Abdi
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2021, 48 (04)